Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
about
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future PerspectivesImplication of hepatokines in metabolic disorders and cardiovascular diseasesThe FGF21-adiponectin axis in controlling energy and vascular homeostasisUnderstanding Fibroblasts in Order to Comprehend the Osteopathic Treatment of the FasciaTranscriptional regulation of fibroblast growth factor 21 expressionRegulation of Long Bone Growth in Vertebrates; It Is Time to Catch UpFGF21 contributes to neuroendocrine control of female reproduction.Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.Recent research on the growth plate: Recent insights into the regulation of the growth plateEffect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.Role of dietary fats in modulating cardiometabolic risk during moderate weight gain: a randomized double-blind overfeeding trial (LIPOGAIN study).GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging.Biomarkers of insulin sensitivity and insulin resistance: Past, present and future.FGF21 protects against ox-LDL induced apoptosis through suppressing CHOP expression in THP1 macrophage derived foam cells.High-fat diet and FGF21 cooperatively promote aerobic thermogenesis in mtDNA mutator mice.Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis.Wnt/β-catenin signaling modulates corneal epithelium stratification via inhibition of Bmp4 during mouse developmentDecreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying MechanismsMetformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21Transcription factor ATF4 directs basal and stress-induced gene expression in the unfolded protein response and cholesterol metabolism in the liver.Features of an altered AMPK metabolic pathway in Gilbert's Syndrome, and its role in metabolic healthAssociation of metabolic syndrome with serum fibroblast growth factor 21 in kidney transplanted patients.FGF21 regulates metabolism and circadian behavior by acting on the nervous systemThe Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease.What we talk about when we talk about fat.Role of Renal Sinus Adipose Tissue in Obesity-induced Renal Injury.Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Fibroblast growth factor 21, assisted by elevated glucose, activates paraventricular nucleus NUCB2/Nesfatin-1 neurons to produce satiety under fed states.Elucidating fish oil-induced milk fat depression in dairy sheep: Milk somatic cell transcriptome analysis.Adiponectin as a tissue regenerating hormone: more than a metabolic function.Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.Methylation of the FGFR2 gene is associated with high birth weight centile in humans.Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents.Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism.The Influence of Bariatric Surgery on Serum Bile Acids in Humans and Potential Metabolic and Hormonal Implications: a Systematic Review.Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.A wellness study of 108 individuals using personal, dense, dynamic data clouds.
P2860
Q26747009-CD8840D7-58EB-4459-840C-049DD0F6524AQ26751147-6988A78D-A011-499D-A78A-2D0B5A734E9FQ26753369-C3134C22-97A7-473B-A893-921474A4634AQ26781823-91E04372-0362-4789-B12A-6521ADFDCEBDQ27024818-480402DD-FFF5-44C6-A491-C7A73ADF4C6DQ28083996-C0A0831C-C47C-4072-8430-D85C84770855Q30414627-E35FABD1-BF33-41D3-AE70-CD3C70412E40Q33895173-B251D13B-DA2D-41F2-B059-023170A5A72BQ34046963-7518FB19-1A0B-47B0-8429-AF9299A92B09Q34158496-7574D98F-BCF5-42FC-86CC-60BB67F1D641Q34827887-4681719B-5763-4797-9C25-C55BF1B81916Q35070738-F539596D-FD04-46C1-A923-DC55E401E93FQ35086484-0A129693-EC40-478F-9FA9-B01E7E253F29Q35537498-905F7A23-1702-4F84-BB96-6A541CE41359Q35652813-BCC79EBF-2BCD-4F6F-801C-F10D61C6E2B6Q35724830-1EB10082-EA92-4380-A1B4-F7C612B76DBEQ35865700-2DBE6776-DF36-465A-ABC7-D80AA8B834BAQ36188382-7E398FF2-102F-46F4-BC96-D9064F66B653Q36245082-B2421DCA-3003-4D49-8971-0B9867D4F755Q36549274-082794F9-FFC5-4210-AD69-B96A866199B9Q36556380-D35193DD-0F32-46AD-A3DB-2EDDEE4FF7DBQ36849447-01D88BC3-122C-42DA-A716-11C14F44D596Q37116706-BC17E6D0-A8E7-497F-99A6-267FAB689031Q37130005-A76C8C6B-5084-421C-8427-0DFB9D6587A0Q37161082-5A96F81B-CCB9-42D2-B1FD-A80BD1539468Q37566373-4D379F02-612E-4B0A-B4EA-CBD8459CF43EQ37601812-2CF23E26-91DD-4A11-9698-D6461AF029B8Q37604920-23A02947-AED7-402E-B76B-926C8718BC44Q37689828-C0F94363-B34E-406B-B802-48A91233BD6FQ37736500-F296D2CF-9917-4722-9BFD-DAECFA4514E3Q37737986-EA9662F3-ACCB-4187-B339-FF0910883466Q38169963-5B18943D-91C3-49F7-B694-2EEB870AADD9Q38201778-F499F895-07F3-4BCC-867B-90F844838A24Q38272309-56DC24C0-43D7-446C-8DF1-162913BD20E9Q38285703-23DAA237-CD50-4254-AFBD-A377BBE9DA1DQ38303572-89057EE7-1D37-4F73-AB4C-4B56BACDFA0CQ38579826-A4AB04B6-5D85-43E5-93EA-E6E5E182C0EBQ38633258-1E4C4B5C-203C-4340-A1EB-0781AD61BCC5Q38665591-DAB638B0-4FA2-4809-902E-5155F42DC22BQ38675875-223B95CF-6079-4756-A122-BFD7261C5A25
P2860
Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
@en
type
label
Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
@en
prefLabel
Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
@en
P2093
P2860
P356
P1476
Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives
@en
P2093
P2860
P304
P356
10.1111/CEN.12095
P50
P577
2013-04-01T00:00:00Z